Literature DB >> 23609795

miRNAGE-34 induces cardiac damAGE.

Costanza Emanueli1, Thomas Thum.   

Abstract

Small non-coding microRNAs (miRNAs, miRs) regulate gene expression in virtually all cells, and they have been implicated in cardiovascular disease and aging. In a paper recently published in Nature, miR-34a was identified as an aging-associated apoptotic and overall damaging factor for the heart.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23609795      PMCID： PMC3698632          DOI： 10.1038/cr.2013.57

Source DB:  PubMed          Journal:  Cell Res        ISSN： 1001-0602            Impact factor:   25.617


  12 in total

1.  Regulation of cardiac microRNAs by bone marrow mononuclear cell therapy in myocardial infarction.

Authors:  Kazuma Iekushi; Florian Seeger; Birgit Assmus; Andreas M Zeiher; Stefanie Dimmeler
Journal:  Circulation       Date:  2012-03-08       Impact factor: 29.690

2.  Silent information regulator 1 protects the heart from ischemia/reperfusion.

Authors:  Chiao-Po Hsu; Peiyong Zhai; Takanobu Yamamoto; Yasuhiro Maejima; Shouji Matsushima; Nirmala Hariharan; Dan Shao; Hiromitsu Takagi; Shinichi Oka; Junichi Sadoshima
Journal:  Circulation       Date:  2010-11-08       Impact factor: 29.690

3.  MicroRNA-34a regulates cardiac ageing and function.

Authors:  Reinier A Boon; Kazuma Iekushi; Stefanie Lechner; Timon Seeger; Ariane Fischer; Susanne Heydt; David Kaluza; Karine Tréguer; Guillaume Carmona; Angelika Bonauer; Anton J G Horrevoets; Nathalie Didier; Zenawit Girmatsion; Peter Biliczki; Joachim R Ehrlich; Hugo A Katus; Oliver J Müller; Michael Potente; Andreas M Zeiher; Heiko Hermeking; Stefanie Dimmeler
Journal:  Nature       Date:  2013-02-20       Impact factor: 49.962

4.  TRF2 functions as a protein hub and regulates telomere maintenance by recognizing specific peptide motifs.

Authors:  Hyeung Kim; Ok-Hee Lee; Huawei Xin; Liuh-Yow Chen; Jun Qin; Heekyung Kate Chae; Shiaw-Yih Lin; Amin Safari; Dan Liu; Zhou Songyang
Journal:  Nat Struct Mol Biol       Date:  2009-03-15       Impact factor: 15.369

5.  Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function.

Authors:  Bianca C Bernardo; Xiao-Ming Gao; Catherine E Winbanks; Esther J H Boey; Yow Keat Tham; Helen Kiriazis; Paul Gregorevic; Susanna Obad; Sakari Kauppinen; Xiao-Jun Du; Ruby C Y Lin; Julie R McMullen
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-09       Impact factor: 11.205

Review 6.  The biology of Ku and its potential oncogenic role in cancer.

Authors:  Charles Gullo; Melvin Au; Ge Feng; Gerrard Teoh
Journal:  Biochim Biophys Acta       Date:  2006-01-25

7.  PNUTS functions as a proto-oncogene by sequestering PTEN.

Authors:  Sridhar Kavela; Swapnil R Shinde; Raman Ratheesh; Kotapalli Viswakalyan; Murali D Bashyam; Swarnalata Gowrishankar; Mohana Vamsy; Sujit Pattnaik; Subramanyeshwar Rao; Regulagadda A Sastry; Mukta Srinivasulu; Junjie Chen; Subbareddy Maddika
Journal:  Cancer Res       Date:  2012-11-01       Impact factor: 12.701

8.  SIRT1 controls endothelial angiogenic functions during vascular growth.

Authors:  Michael Potente; Laleh Ghaeni; Danila Baldessari; Raul Mostoslavsky; Lothar Rossig; Franck Dequiedt; Judith Haendeler; Marina Mione; Elisabetta Dejana; Frederick W Alt; Andreas M Zeiher; Stefanie Dimmeler
Journal:  Genes Dev       Date:  2007-10-15       Impact factor: 11.361

9.  Transcriptional activation of miR-34a contributes to p53-mediated apoptosis.

Authors:  Nina Raver-Shapira; Efi Marciano; Eti Meiri; Yael Spector; Nitzan Rosenfeld; Neta Moskovits; Zvi Bentwich; Moshe Oren
Journal:  Mol Cell       Date:  2007-05-31       Impact factor: 17.970

10.  The microRNA miR-34 modulates ageing and neurodegeneration in Drosophila.

Authors:  Nan Liu; Michael Landreh; Kajia Cao; Masashi Abe; Gert-Jan Hendriks; Jason R Kennerdell; Yongqing Zhu; Li-San Wang; Nancy M Bonini
Journal:  Nature       Date:  2012-02-15       Impact factor: 49.962
View more
  6 in total

Review 1.  Heart failure with preserved ejection fraction: molecular pathways of the aging myocardium.

Authors:  Francesco S Loffredo; Andriana P Nikolova; James R Pancoast; Richard T Lee
Journal:  Circ Res       Date:  2014-06-20       Impact factor: 17.367

Review 2.  MicroRNAs in vascular tissue engineering and post-ischemic neovascularization.

Authors:  Massimo Caputo; Jaimy Saif; Cha Rajakaruna; Marcus Brooks; Gianni D Angelini; Costanza Emanueli
Journal:  Adv Drug Deliv Rev       Date:  2015-05-14       Impact factor: 15.470

3.  Integrative Analysis of miRNA and mRNA Expression Profiles Associated With Human Atrial Aging.

Authors:  Yan Yao; Chenxi Jiang; Fan Wang; Han Yan; Deyong Long; Jinghua Zhao; Jiangang Wang; Chunxiao Zhang; Yang Li; Xiaoli Tian; Qing K Wang; Gang Wu; Zhihui Zhang
Journal:  Front Physiol       Date:  2019-09-19       Impact factor: 4.566

4.  Silencing of miR-34a attenuates cardiac dysfunction in a setting of moderate, but not severe, hypertrophic cardiomyopathy.

Authors:  Bianca C Bernardo; Xiao-Ming Gao; Yow Keat Tham; Helen Kiriazis; Catherine E Winbanks; Jenny Y Y Ooi; Esther J H Boey; Susanna Obad; Sakari Kauppinen; Paul Gregorevic; Xiao-Jun Du; Ruby C Y Lin; Julie R McMullen
Journal:  PLoS One       Date:  2014-02-27       Impact factor: 3.240

5.  MicroRNA profiling of pericardial fluid samples from patients with heart failure.

Authors:  Suvi M Kuosmanen; Juha Hartikainen; Mikko Hippeläinen; Hannu Kokki; Anna-Liisa Levonen; Pasi Tavi
Journal:  PLoS One       Date:  2015-03-12       Impact factor: 3.240

6.  PD-1 inhibitor inducing exosomal miR-34a-5p expression mediates the cross talk between cardiomyocyte and macrophage in immune checkpoint inhibitor-related cardiac dysfunction.

Authors:  Wenzheng Xia; Hanbin Chen; Didi Chen; Congying Xie; Meng Hou; Yijia Ye
Journal:  J Immunother Cancer       Date:  2020-10       Impact factor: 13.751
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.